Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,857 papers from all fields of science
Search
Sign In
Create Free Account
YP 279
Known as:
YP-279
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
5-dimethyldithiocarbamylpicolinic acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
Enhancement of dopamine-induced stimulation of pancreatic secretion by 5-dimethyldithiocarbamylpicolinic acid (YP-279), a dopamine beta-hydroxylase inhibitor.
K. Iwatsuki
,
K. Hashimoto
Japanese Journal of Pharmacology
1979
Corpus ID: 38322134
Effect of 5-dimethyldithiocarbamylpicolinic acid (YP-279), a dopamine beta-hydroxylase inhibitor, on the secretion of pancreatic…
Expand
1977
1977
Failure of Peripheral Dopamine β-Hydroxylase Inhibitor to Affect Discriminated Sidman Avoidance Learning in Rats under Long-Term Training
Y. Tamaki
Psychological Reports
1977
Corpus ID: 46527541
5-dimethyldithiocarbamylpicolinic acid (YP-279) is a selective inhibitor of peripheral dopamine β-hydroxylase (DβH). After 72…
Expand
1976
1976
Behavioral Depression in Sidman Avoidance Learning Induced by Dopamine β-Hydroxylase Inhibitors
Y. Tamaki
,
Hiroyoshi Hidaka
Psychological Reports
1976
Corpus ID: 38037916
This study attempted to discriminate between the peripheral and the central effects of dopamine β-hydroxylase (DßH) inhibition on…
Expand
1975
1975
Inhibition of dopamine beta-hydroxylase in blood vessels by picolinic acid derivatives in vivo and their anthypertensive effects.
H. Hidaka
,
F. Shoka
,
Y. Hashizume
,
N. Takemoto
,
M. Yamamoto
Japanese Journal of Pharmacology
1975
Corpus ID: 25405350
The effect of picolinic acid derivatives, 5-butylpicolinic (fusaric) acid (FA), 5-(3',4'-DIBROMOBUTYL)PICOLINIC ACID(BPR2FA)and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE